In vitro replication capacity of HIV-2 variants from long-term aviremic individuals

被引:31
作者
Blaak, Hetty
van der Ende, Marchina E.
Boers, Patrick H. M.
Schuitemaker, Hanneke
Osterhaus, Albert D. M. E.
机构
[1] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands
[2] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
[3] Univ Amsterdam, Dept Clin Viroimmunol, Acad Med Ctr, NL-1066 CX Amsterdam, Netherlands
[4] Univ Amsterdam, Dept Clin Viroimmunol, Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands
关键词
HIV-2; biological clone; replication rate; aviremia; long-term nonprogressor; pathogenesis;
D O I
10.1016/j.virol.2006.05.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To establish whether efficient suppression of virus replication in HIV-2-infected individuals is associated with low replicative capacity of HIV-2, replication kinetics of HIV-2 variants from long-term aviremic individuals was analyzed and compared with that of the relatively slow-replicating HIV-1 variants from asymptomatics and long-term nonprogressors (AS/LTNP). On average, HIV-2 from aviremic individuals had lower replication rates than HIV-1 variants from AS/LTNP in cells of 8 donors (0.45 log(10) [range 0.14-0.77] vs. 0.58 log(10) [range 0.32-0.99] pg RT/ml/day, P = 0.036). The relatively low replication rate of HIV-2 compared to HIV-1 variants was not related to different sensitivities to inhibition by CD8(+) T cells or different degrees of infectivity. HIV-2 replication rates increased with progressive infection and with switch from CCR5 to CXCR4 usage. The relatively low replicative capacity of HIV-2 variants from aviremic individuals likely contributes to the low viral load and benign course of infection in these individuals. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 43 条
[1]   REPLICATIVE CAPACITY OF HIV-2, LIKE HIV-1, CORRELATES WITH SEVERITY OF IMMUNODEFICIENCY [J].
ALBERT, J ;
NAUCLER, A ;
BOTTIGER, B ;
BROLIDEN, PA ;
ALBINO, P ;
OUATTARA, SA ;
BJORKEGREN, C ;
VALENTIN, A ;
BIBERFELD, G ;
FENYO, EM .
AIDS, 1990, 4 (04) :291-295
[2]   The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates [J].
Ariën, KK ;
Abraha, A ;
Quiñones-Mateu, ME ;
Kestens, L ;
Vanham, G ;
Arts, EJ .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8979-8990
[3]  
ASJO B, 1986, LANCET, V2, P660
[4]   Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome [J].
Barker, E ;
Mackewicz, CE ;
Reyes-Terán, G ;
Sato, A ;
Stranford, SA ;
Fujimura, SH ;
Christopherson, C ;
Chang, SY ;
Levy, JA .
BLOOD, 1998, 92 (09) :3105-3114
[5]  
Berry N, 1998, J Hum Virol, V1, P457
[6]   Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers [J].
Berry, N ;
Jaffar, S ;
Van der Loeff, MS ;
Ariyoshi, K ;
Harding, E ;
N'Gom, PT ;
Dias, F ;
Wilkins, A ;
Ricard, D ;
Aaby, P ;
Tedder, R ;
Whittle, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) :1167-1173
[7]   CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia [J].
Blaak, H ;
Boers, PHM ;
Gruters, RA ;
Schuitemaker, H ;
van der Ende, ME ;
Osterhaus, ADME .
JOURNAL OF VIROLOGY, 2005, 79 (03) :1686-1700
[8]   HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes [J].
Blaak, H ;
Boers, PHM ;
Schutten, M ;
van der Endeñ, ME ;
Osterhaus, ADME .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) :777-782
[9]   In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection [J].
Blaak, H ;
Brouwer, M ;
Ran, LJ ;
de Wolf, F ;
Schuitemaker, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :600-610
[10]   Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 [J].
Bleiber, G ;
Munoz, M ;
Ciuffi, A ;
Meylan, P ;
Telenti, A .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3291-3300